This increased tumor growth was accompanied by an increase in PMNs and a decrease in CD11b+ DCs in the primary TME, consistent with a heightened immune-suppressive state (Supplemental Figure 2E, middle). The gene discussed is ITGAM; the disease is neoplasm.